Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
LLY Eli Lilly and Company daily Stock Chart
LLY [NYSE]
Eli Lilly and Company
Healthcare | Drug Manufacturers - Major | USA
financial highlights | statements
IndexS&P 500 P/E35.75 EPS (ttm)3.30 Insider Own11.40% Shs Outstand1.05B Perf Week-1.63%
Market Cap123.61B Forward P/E17.85 EPS next Y6.61 Insider Trans-1.87% Shs Float1.03B Perf Month-9.14%
Income3.41B PEG3.18 EPS next Q1.30 Inst Own81.80% Short Float3.39% Perf Quarter-0.67%
Sales24.56B P/S5.03 EPS this Y102.80% Inst Trans0.15% Short Ratio2.04 Perf Half Y5.43%
Book/sh9.72 P/B12.14 EPS next Y18.09% ROA7.40% Target Price124.93 Perf Year47.13%
Cash/sh7.72 P/C15.29 EPS next 5Y11.23% ROE26.40% 52W Range77.09 - 132.13 Perf YTD1.97%
Dividend2.58 P/FCF61.74 EPS past 5Y-5.30% ROI14.70% 52W High-11.41% Beta0.29
Dividend %2.19% Quick Ratio1.40 Sales past 5Y1.20% Gross Margin73.80% 52W Low51.84% ATR2.21
Employees38680 Current Ratio1.70 Sales Q/Q4.50% Oper. Margin15.20% RSI (14)33.59 Volatility2.13% 1.75%
OptionableYes Debt/Eq1.30 EPS Q/Q416.90% Profit Margin13.20% Rel Volume0.20 Prev Close118.00
ShortableYes LT Debt/Eq1.18 EarningsApr 30 BMO Payout71.50% Avg Volume17.19M Price117.05
Recom2.50 SMA20-5.68% SMA50-6.16% SMA2004.04% Volume319,896 Change-0.81%
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-07-17Reiterated Barclays Overweight $85 → $90
Apr-25-19 07:19AM  Eli Lilly's Lartruvo is being pulled from the market, but patients who are already taking the drug will still have access under new program MarketWatch
06:45AM  Lilly to Establish an Access Program for Patients as it Prepares to Withdraw Lartruvo from the Global Market PR Newswire
Apr-24-19 04:25PM  Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-23-19 10:33AM  Teva stops testing its migraine drug as cluster headache treatment Reuters
08:08AM  The Daily Biotech Pulse: FDA Accepts Alder's Migraine Drug Application, Gritstone Offering, Lilly's Chinese Sale Benzinga
Apr-22-19 10:05PM  Lilly Announces Sale of Legacy Antibiotics Brands and Manufacturing Facility in China PR Newswire
05:50PM  The best companies for employees in 2019 Yahoo Finance
11:13AM  Eli Lilly Falls Despite Positive Phase 3 Results From Taltz Study TheStreet.com
11:12AM  Update: Eli Lilly (NYSE:LLY) Stock Gained 97% In The Last Five Years Simply Wall St.
10:24AM  Eli Lilly-Pfizer's Non-Opioid Painkiller Faces Safety, Efficacy Concerns Benzinga
08:00AM  Eli Lilly stock down 3.4% despite positive Phase 3 findings for Taltz MarketWatch
06:45AM  Lilly Announces Positive Top-Line Results for COAST-X, a 52-Week Placebo-Controlled Study of Taltz® (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis PR Newswire
06:30AM  Lilly and Avidity Biosciences Announce Licensing and Research Collaboration PR Newswire
Apr-18-19 07:01PM  Jim Cramer: Diversification Is Good for Offense, Not Just Defense TheStreet.com
06:37PM  Pfizer, Lilly shares decline as osteoarthritis drug misses goals in study MarketWatch
06:14PM  Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study Reuters
09:17AM  Novo Nordisk's (NVO) Share Price Rises YTD on Strong Pipeline Zacks
Apr-17-19 10:14AM  Double Top Spells Trouble for 3 Health Care Stocks Investopedia
Apr-16-19 06:54PM  Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales Zacks
05:54PM  Technician lays out the best bets in biotech CNBC Videos
Apr-15-19 10:07AM  J&J's Erdafitinib Gets FDA Approval for Urothelial Cancer Zacks
Apr-11-19 03:33PM  Biotechnology Market on a Tear: 5 ETFs in Spotlight Zacks
11:13AM  Eli Lilly Stock Was Downgraded Because Everyone Already Knows Its Good Barrons.com
10:50AM  The Zacks Analyst Blog Highlights: Eli Lilly, Altria, Becton, Dickinson, T-Mobile and General Motors Zacks
07:56AM  Here are the biggest analyst calls of the day: Apple, Chipotle, IBM, Xerox, U.S. Steel & more CNBC
06:00AM  Algorithms, Derivatives and Manias- A Day of Reckoning MoneyShow
Apr-10-19 04:30PM  Lilly Confirms Date and Conference Call for First-Quarter 2019 Financial Results Announcement PR Newswire
02:12PM  Top Stock Reports for Eli Lilly, Altria & Becton Dickinson Zacks
11:11AM  Is AstraZeneca Stock Worth Buying Before Earnings? InvestorPlace
09:24AM  Sanofi sets a fixed price of insulin at $99 per month for some patients CNBC
09:15AM  Why Eli Lilly (LLY) is a Great Dividend Stock Right Now Zacks
08:45AM  Looking for a Growth Stock? 3 Reasons Why Lilly (LLY) is a Solid Choice Zacks
05:04AM  Sanofi to cut U.S. insulin costs for some patients to $99 per month Reuters
Apr-09-19 02:29PM  Heated debate over high drug costs returns to Capitol Hill Associated Press
10:06AM  United Therapeutics Discontinues PAH Drug After Study Fails Zacks
Apr-06-19 09:41AM  Lawsuit over migraine deal could be good for Amgen, analysts say MarketWatch
03:41AM  Pfizer's Ibrance Gets FDA Approval for Breast Cancer in Men Zacks
Apr-05-19 09:26PM  Pfizer's Ibrance Gets FDA Approval for Breast Cancer in Men Zacks
10:14AM  Novartis & Amgen in Legal Dispute Over Migraine Drug Aimovig Zacks
09:17AM  Dow 30 Stock Roundup: WBA Q2 Earnings Disappoint, PFE Lung Cancer Drug Gets EU Approval Zacks
08:00AM  Health Day Checkup of Medical ETFs: 5 Top Picks Zacks
Apr-04-19 01:14PM  Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Investor's Business Daily
Apr-03-19 09:58AM  Alector (ALEC) Initiates Phase I Alzheimer's Study on AL003 Zacks
07:21AM  Cigna launches program to cap out-of-pocket insulin costs at $25/month Reuters
Apr-02-19 10:09AM  AVEO Reports Positive Results on Leukemia Drug, Shares Up Zacks
10:04AM  Merck's Keytruda Gets Nod for First-Line Lung Cancer in China Zacks
09:36AM  Teva's Anti-CGRP Injection Ajovy Gets Approval in Europe Zacks
Apr-01-19 08:53AM  3 Big Pharma Stocks to Add to Your Portfolio This April Zacks
07:02AM  BMOs Got A Point About Teva Stock, But Are Investors Willing To Listen? InvestorPlace
05:00AM  Arteaus Therapeutics Sells Emgality Royalty to Royalty Pharma for $260 Million PR Newswire
Mar-29-19 06:04PM  This Dow stock could be a way to play catch-up to the rally CNBC
03:23PM  Wall Street is buzzing about Gileads rheumatoid arthritis drug. Heres why MarketWatch
07:22AM  Jim Cramer Advised His Viewers On Canopy Growth, DowDuPont And More Benzinga
Mar-28-19 07:20PM  Cramer's lightning round: Eli Lilly is a low-reward, high-risk stock CNBC Videos
Mar-27-19 02:47PM  5 Cancer-Fighting Stocks to Boost Portfolio Gains Zacks
10:48AM  Lilly (LLY) Signs New Immunology Deal With Private Biotech Zacks
07:52AM  The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO Benzinga
Mar-26-19 07:45PM  Better Buy: Eli Lilly vs. GlaxoSmithKline Motley Fool
04:30PM  Lilly and ImmuNext Announce Licensing and Research Collaboration PR Newswire
12:28PM  Were Hedge Funds Right About Eli Lilly and Company (LLY)? Insider Monkey
07:42AM  Eli Lilly and Company (NYSE:LLY): Whats The Analyst Consensus Outlook? Simply Wall St.
Mar-25-19 07:40AM  Recent Analysis Shows Mastercard, Halliburton, Keysight Technologies, Eli Lilly, Wabash National, and Regeneron Pharmaceuticals Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
12:22AM  PRESS DIGEST - Wall Street Journal - March 25 Reuters
Mar-22-19 05:50PM  Eli Lilly (LLY) Stock Moves -0.01%: What You Should Know Zacks
06:01AM  Bull of the Day: DexCom (DXCM) Zacks
Mar-21-19 08:00PM  Better Buy: AbbVie vs. Eli Lilly Motley Fool
09:54AM  Alkermes Focuses on Pipeline, Depends on Partners for Funds Zacks
09:46AM  Biogen shares tank nearly 30% after pulling key Alzheimers drug trial Yahoo Finance
07:12AM  9 High-Margin Stocks Seen Leading in Fed's New Dovish Era Investopedia
Mar-20-19 04:32PM  Eli Lilly Stock Is Up Because UBS Sees Reasons to Be Bullish Barrons.com
08:45AM  NCCN Announces Six Quality Improvement Projects in Gastric Cancer Care Approved for Collaboration with Lilly Oncology PR Newswire
Mar-16-19 01:52PM  The Numbers Say Eli Lilly Stock Has Still More Upside For Investors InvestorPlace
Mar-15-19 10:31AM  Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others Zacks
08:00AM  The Case Against Pfizer Stock and the Rest of the Industry InvestorPlace
Mar-14-19 05:01AM  Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades Investopedia
Mar-13-19 01:10PM  Lilly's Cyramza Successful in Phase III First-Line NSCLC Study Zacks
08:37AM  FDA medical adviser: 'Congress is owned by pharma' Yahoo Finance
08:00AM  Lilly Announces Final Results of Elanco Exchange Offer PR Newswire
Mar-12-19 05:50PM  Eli Lilly (LLY) Flat As Market Gains: What You Should Know Zacks
02:06PM  BioNtech hires banks for IPO worth up to $800 million - sources Reuters
01:29PM  Biontech stock offering could be worth as much as $800 million-sources Reuters
12:10PM  Eli Lilly Could Sustain Industry-Leading Growth, Says Bullish JPMorgan Benzinga
10:46AM  Eli Lillys Latest Move Proves the American Healthcare System Is Broken InvestorPlace
10:20AM  Allergan Announces FDA Acceptance of Migraine Candidate NDA Zacks
07:33AM  Here are the biggest analyst calls of the day: Tesla, Boeing, Coca-Cola, Monster Beverage, Eli Lilly CNBC
07:18AM  Lilly's combo therapy succeeds in late-stage lung cancer study Reuters
06:55AM  Lilly's combo treatment meets main goal in lung cancer late-stage study Reuters
06:45AM  Lilly's CYRAMZA® (ramucirumab) Phase 3 RELAY Trial Met Primary Endpoint, Significantly Improving Progression-Free Survival in First-Line Treatment of Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer PR Newswire
Mar-11-19 09:28PM  Dicerna Pharmaceuticals Inc (DRNA) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:01PM  Elanco Animal Health Begins Trading After Eli Lilly Split Benzinga
12:59PM  Stocks - Dow Reverses Early Losses to End Higher as Tech Rallies Investing.com
10:06AM  The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's Zacks
06:45AM  Lilly Announces Preliminary Results of Elanco Exchange Offer PR Newswire
Mar-08-19 01:45PM  Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs Zacks
11:04AM  Celldex (CLDX) Q4 Loss Narrower than Expected, Sales Beat Zacks
09:30AM  Lilly (LLY) Up 7.5% Since Last Earnings Report: Can It Continue? Zacks
07:30AM  Lilly to Participate in Barclays Global Healthcare Conference PR Newswire
Mar-07-19 05:15PM  Lilly to Participate in Cowen Health Care Conference PR Newswire
08:48AM  Allergan's Depression Candidate Fails in Studies, Stock Down Zacks
06:45AM  Lilly Announces Final Exchange Ratio of 4.5121 for Elanco Exchange Offer PR Newswire
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as migraine prevention. In addition, it offers immunology products for the treatment of adults with rheumatoid arthritis, as well as for the treatment of plaque psoriasis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia, and acute coronary syndrome. Further, the company provides animal health products, such as cattle feed additives; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and enteric diseases in swine and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; Dicerna Pharmaceuticals; and AC Immune SA. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zulueta Alfonso GSVP & President, Lilly Int'lApr 12Sale124.6510,0001,246,50057,806Apr 16 02:48 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMApr 12Sale125.154,735592,58522,085Apr 16 02:36 PM
Shah Aarti S.SVP & CIOApr 05Sale125.851,800226,53018,425Apr 08 02:54 PM
LILLY ENDOWMENT INC10% OwnerMar 26Sale131.41205,00026,938,688116,810,304Mar 27 02:57 PM
Zakrowski Donald AChief Accounting OfficerMar 22Sale128.501,000128,5004,595Mar 22 03:16 PM
Fry Stephen FSVP, HR & DiversityMar 12Sale123.1614,8471,828,557109,663Mar 13 12:47 PM
LILLY ENDOWMENT INC10% OwnerMar 01Sale128.43210,00026,971,215117,015,304Mar 04 02:13 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale127.011,000127,0105,595Mar 05 03:51 PM
LILLY ENDOWMENT INC10% OwnerFeb 28Sale126.73200,00025,345,017117,225,304Mar 01 01:25 PM
LILLY ENDOWMENT INC10% OwnerFeb 22Sale124.19195,00024,217,635117,425,304Feb 25 04:06 PM
LILLY ENDOWMENT INC10% OwnerFeb 19Sale122.48205,00025,108,513117,620,304Feb 20 01:35 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048082Feb 20 03:52 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 15Sale121.0025,0003,025,000132,962Feb 20 03:37 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.003,221054,175Feb 06 08:10 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.009,722050,946Feb 05 07:09 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0012,2220131,708Feb 05 07:04 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0012,7780102,548Feb 05 06:59 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.008,8890109,100Feb 05 06:55 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0012,2220136,756Feb 05 06:49 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.003,333020,901Feb 05 06:43 PM
LILLY ENDOWMENT INC10% OwnerJan 17Sale118.33136,57716,161,281117,825,304Jan 18 01:14 PM
LILLY ENDOWMENT INC10% OwnerJan 16Sale117.871,657195,315117,961,881Jan 17 01:15 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale117.7451,7666,095,136117,963,538Jan 16 02:36 PM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 10Sale112.9225,0002,822,95950,954Dec 12 03:15 PM
LILLY ENDOWMENT INC10% OwnerDec 04Sale119.0015,5001,844,536118,015,304Dec 06 03:43 PM
White Anne E.SVP & Pres-Lilly OncologyDec 02Option Exercise0.007,500017,103Dec 04 03:14 PM
LILLY ENDOWMENT INC10% OwnerNov 29Sale117.42185,00021,722,429118,030,804Nov 30 11:52 AM
LILLY ENDOWMENT INC10% OwnerNov 28Sale115.57190,00021,957,939118,215,804Nov 29 10:55 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.31195,00022,485,572118,405,804Nov 20 02:40 PM
LILLY ENDOWMENT INC10% OwnerNov 16Sale113.74200,00022,747,000118,600,804Nov 19 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 13Sale113.412,460278,979118,800,804Nov 14 10:44 AM
LILLY ENDOWMENT INC10% OwnerNov 12Sale113.48202,54022,984,877118,803,264Nov 13 10:51 AM
LILLY ELI & CO10% OwnerNov 06Sale14.00700,0009,800,0003,148,647Nov 08 11:34 AM
Norton JohnaSenior VP, Global QualityNov 03Option Exercise0.003,133019,225Nov 06 01:25 PM
LILLY ENDOWMENT INC10% OwnerOct 17Sale113.25174,69619,783,623119,005,804Oct 18 02:26 PM
LILLY ENDOWMENT INC10% OwnerOct 09Sale115.9110,6721,237,013119,180,500Oct 10 01:17 PM
LILLY ENDOWMENT INC10% OwnerOct 08Sale115.9114,6321,696,039119,191,172Oct 09 01:14 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale112.67116,03813,073,950119,205,804Oct 05 02:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lOct 04Sale114.647,000802,48045,224Oct 05 02:08 PM
LILLY ENDOWMENT INC10% OwnerOct 03Sale109.0178,9628,607,253119,321,842Oct 04 02:29 PM
LILLY ENDOWMENT INC10% OwnerSep 28Sale107.31107,55311,541,082119,400,804Oct 01 11:53 AM
LILLY ENDOWMENT INC10% OwnerSep 27Sale107.0092,4479,891,644119,508,357Sep 28 10:36 AM
LILLY ENDOWMENT INC10% OwnerSep 26Sale106.63134,41014,332,373119,600,804Sep 27 12:26 PM
LILLY ENDOWMENT INC10% OwnerSep 25Sale106.4155,5905,915,165119,735,214Sep 26 01:49 PM
LILLY ELI & CO10% OwnerSep 24Sale16.362,02733,1623,848,647Sep 26 02:50 PM
LILLY ELI & CO10% OwnerSep 18Sale14.566,870100,0273,850,674Sep 20 04:50 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 18Sale107.003,000321,00052,224Sep 19 05:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 17Sale105.613,000316,83055,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 17Sale14.586,865100,0923,857,544Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 14Sale14.589,009131,3513,864,409Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 13Sale14.3220,900299,2883,873,418Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 12Sale14.8310,059149,1753,894,318Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 11Sale14.8711,277167,6893,904,377Sep 12 04:39 PM
LILLY ELI & CO10% OwnerSep 10Sale14.444,50064,9803,915,654Sep 12 04:39 PM
LILLY ENDOWMENT INC10% OwnerSep 07Sale106.76180,00019,217,055119,790,804Sep 10 12:44 PM
Zakrowski Donald AChief Accounting OfficerSep 04Sale105.5760063,3423,530Sep 04 04:50 PM
LILLY ELI & CO10% OwnerAug 31Sale14.267009,9823,920,154Sep 04 03:38 PM
LILLY ENDOWMENT INC10% OwnerAug 30Sale105.42190,00020,030,370119,970,804Aug 31 09:07 AM
LILLY ELI & CO10% OwnerAug 30Sale14.353,44049,3643,920,854Aug 31 12:40 PM
LILLY ELI & CO10% OwnerAug 29Sale14.262,31232,9693,924,294Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 20Sale105.89195,00020,647,575120,160,804Aug 21 02:12 PM
LILLY ENDOWMENT INC10% OwnerAug 16Sale104.50200,00020,899,800120,355,804Aug 17 03:08 PM
LILLY ENDOWMENT INC10% OwnerAug 15Sale103.23151,79315,669,440120,555,804Aug 16 02:52 PM
LILLY ELI & CO10% OwnerAug 14Sale14.283,00042,8403,926,606Aug 16 03:34 PM
LILLY ELI & CO10% OwnerAug 13Sale14.334,53164,9293,929,606Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 10Sale103.063,587369,676120,707,597Aug 13 03:41 PM
LILLY ELI & CO10% OwnerAug 10Sale14.281,89827,1033,934,137Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 07Sale103.2224,6202,541,326120,711,184Aug 08 01:28 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale102.15195,00019,918,860120,735,804Aug 07 11:46 AM
LILLY ELI & CO10% OwnerAug 03Sale13.551,65022,3583,936,035Aug 07 03:16 PM
LILLY ELI & CO10% OwnerAug 02Sale13.3119,400258,2143,937,685Aug 03 03:53 PM
LILLY ENDOWMENT INC10% OwnerAug 02Sale99.58190,00018,919,939120,930,804Aug 03 02:31 PM
LILLY ENDOWMENT INC10% OwnerJul 31Sale98.74205,00020,240,873121,120,804Aug 01 01:12 PM
TAI JACKSON PDirectorJul 26Buy95.222,168206,43753,228Jul 27 10:46 AM
LILLY ENDOWMENT INC10% OwnerJul 25Sale94.73190,00017,999,259121,325,804Jul 26 02:17 PM
LILLY ENDOWMENT INC10% OwnerJul 24Sale92.03185,00017,025,985121,515,804Jul 25 11:47 AM
LILLY ENDOWMENT INC10% OwnerJul 06Sale87.44180,00015,738,300121,700,804Jul 09 10:45 AM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39402,394Jul 09 11:58 AM
LILLY ENDOWMENT INC10% OwnerJul 05Sale86.62170,00014,725,740121,880,804Jul 06 11:13 AM
LILLY ENDOWMENT INC10% OwnerJun 15Sale86.65180,00015,597,720122,050,804Jun 18 12:39 PM
Skovronsky DanielSVP, CSO, and Pres. LRLJun 14Buy86.2210,000862,20055,199Jun 14 04:08 PM
LILLY ENDOWMENT INC10% OwnerJun 14Sale86.31107,6989,295,414122,230,804Jun 15 11:00 AM
LILLY ENDOWMENT INC10% OwnerJun 13Sale86.2711,104957,953122,338,502Jun 14 11:58 AM
LILLY ENDOWMENT INC10% OwnerJun 11Sale86.3851,1984,422,637122,349,606Jun 12 02:46 PM
LILLY ENDOWMENT INC10% OwnerJun 04Sale85.13135,47811,532,565122,400,804Jun 05 11:20 AM
LILLY ENDOWMENT INC10% OwnerJun 01Sale85.3139,5223,371,661122,536,282Jun 04 02:25 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 31Sale85.0025,0002,125,000124,534Jun 01 04:22 PM
LILLY ENDOWMENT INC10% OwnerMay 30Sale83.85180,00015,092,640122,575,804May 31 01:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 29Sale82.108,426691,7750May 31 01:05 PM
LILLY ENDOWMENT INC10% OwnerMay 11Sale81.97140,00011,475,940122,755,804May 14 02:29 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 03Sale78.509,027708,620135,458May 03 04:34 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 01Option Exercise0.0020,0000153,201May 03 04:34 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:29 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 01Option Exercise0.0020,0000158,468May 03 04:26 PM
open in yahoo | open in reuters | open in google